A recent study analyzes trends and compares complication rates of joint replacement patients who go home the same day they have surgery versus those who spend one or more nights in the hospital.
Scientists have determined the structure of the molecule associated with amyotrophic lateral sclerosis (ALS) and multiple other neurodegenerative diseases, they suggest, in Nature.
Researchers have developed an injectable therapy based on nanofibers that has enabled paralyzed mice with severe spinal cord injuries to regain the ability to walk.
Leg amputees who receive bone-anchored prosthetics report high levels of satisfaction compared with those who receive conventional devices, according to new study findings published in JBJS Open Access by researchers at Hospital for Special Surgery (HSS) in New York City.
Read More
Exoskeleton-assisted rehabilitation can be beneficial in treating stroke survivors, according to researchers at The University of Texas Health Science Center at Houston (UTHealth), in the Journal of Neural Engineering.
Read More
Researchers in Mount Sinai Health System’s Department of Rehabilitation and Human Performance have received a $2.9 million grant from the National Institutes of Health to study whether a first-of-its-kind brain implant can help restore function in severely paralyzed patients and improve their ability to communicate.
Read More
The National Institute on Aging has awarded a $1.8 million grant to a University of Massachusetts Amherst kinesiologist and her team to study how muscle fatigue and gait changes affect older people’s ability to remain active.
Read More
Adults younger than age 60 whose days are filled with sedentary leisure time and little physical activity have a higher stroke risk than people who are more physically active, according to new research published recently in Stroke.
Read More
Researchers from Massachusetts Institute of Technology have developed a new strategy that could offer much more precise control of prosthetic limbs. They explain their method in Science Translational Medicine.
Read More
Black COVID-19 patients are more likely to have experienced strokes prior to their diagnosis than their non-Black counterparts, according to a study by Penn State College of Medicine researchers, published in the Journal of Stroke and Cerebrovascular Diseases.
Read More
New study results for Tikomed’s platform lead drug candidate ILB in the treatment of patients with amyotrophic lateral sclerosis (ALS), have been published in the Journal of Personalized Medicine.
Read More
Some proteins in cells can separate into small droplets like oil droplets in water, but faults in this process may underlie neurodegenerative diseases in the brains of older people. Now, Rutgers researchers have developed a new method to quantify protein droplets involved in these diseases, which they explain in the journal Biophysical Reports.
Read More
In what is reportedly a first-in-human study, researchers at Feinstein Institutes for Medical Research elicited the sense of touch through a minimally invasive electrode brain implant.
Read More
Data from FIREFISH Part 2, a global study evaluating the efficacy and safety of Evrysdi (risdiplam) in babies aged 1-7 months old with symptomatic Type 1 spinal muscular atrophy (SMA), was published recently in the New England Journal of Medicine, Roche announces.
Read More
A National Institutes of Health (NIH)-funded study published in Science Translational Medicine may point to possible therapeutic target for amyotrophic lateral sclerosis (ALS).
Read More
The US Food and Drug Administration (FDA) has approved Synchron’s Investigational Device Exemption (IDE) application for its flagship product, the Stentrode motor neuroprosthesis, the company reports.
Read More
Bacterial DNA from prosthetic joint infections can be detected in circulating blood and sequenced to identify the bacteria causing the infection, a Hospital for Special Surgery (HSS)-led team of investigators suggests.
Read More
Results of a compassionate-use study released in STEM CELLS Translational Medicine suggest promising results for treating muscular dystrophies with mesenchymal stem cells (MSCs) derived from Wharton’s jelly (WJ), a substance found in the umbilical cord.
Read More